Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08NDA
|
|||
| Former ID |
DIB008007
|
|||
| Drug Name |
ISIS-HBV
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 2 | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis B virus messenger RNA (HBV mRNA) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of ISIS Pharmaceuticals. | |||
| REF 2 | Clinical pipeline report, company report or official report of ISIS Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.